Hong Seng's healthcare arm HS Bio acquires two industrial properties


Hong Seng executive director and HS Bio director Christopher Chan

KUALA LUMPUR: Hong Seng Consolidated Bhd has proposed to acquire a 100% stake in Premiumway Development Sdn Bhd (PDSB) for RM1.09mil.

In a filing with Bursa Malaysia, Hong Seng said its unit Neogenix Laboratoire Sdn Bhd (Neogenix Lab) had entered into a shares sale agreement (SSA) with the Ong Kah Hoe and Ong Kim Chong @ Ong Hwee Choo to undertake the proposed acquisition of one million ordinary shares, or 100% equity interest in PDSB.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

KIP-REIT expects higher footfall across its malls
Oxford Innotech wins RM4.8mil data centre job
Suria Capital appoints Abd Rahman Dahlan as chairman
Ringgit closes higher amid US-EU tariff concerns, easing Japanese government bonds
Shin Yang secures RM117.7mil vessel deal
UOA REIT reports threefold profit increase in 4Q25
Perak Transit appoints Ismail Jamal as general manager
Pantech cautiously positive on outlook
AmBank Group provides RM103.8mil financing for Kedah solar project
Malaysia Aviation Group names Bryan Foong airline business CEO, Low Wen Long strategy chief

Others Also Read